Search Within

Welby Montalvo Ortiz

Refine Results
Formats
  1. Journal Article (5)
  2. Meeting Abstract (3)
Groups
  1. Melanoma Disease Management Team (7)
  2. Center for Hematologic Malignancies (2)
  3. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (2)
  4. Hematologic Malignancies Research (2)
  5. Immunology Program Faculty (2)
  6. Sloan Kettering Institute Faculty (2)

More Groups

People
  1. James Allison (7)
  2. Michael Curran (3)
  3. Myoungjoo Kim (3)
  4. Joseph Sun (2)
  5. Theresa Geiger (2)
  6. Virginia Pedicord (2)

More People

Years
  1. 2015 (1)
  2. 2013 (2)
  3. 2012 (1)
  4. 2011 (3)
  5. 2010 (1)
Publications
  1. Journal of Immunology (2)
  2. Proceedings of the National Academy of Sciences of the United States of America (2)
  3. Cancer Research (1)
  4. Journal of Clinical Oncology (1)
  5. Journal of Experimental Medicine (1)
  6. PLoS ONE (1)
Publishers
  1. National Academy of Sciences (2)
  2. The American Association of Immunologists, Inc (2)
  3. American Association for Cancer Research (1)
  4. American Society of Clinical Oncology (1)
  5. Public Library of Science (1)
  6. Rockefeller University Press (1)

Results (8)

Export to EndNote | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Friends not foes: CTLA-4 blockade and mTOR inhibition cooperate during CD8+ T cell priming to promote memory formation and metabolic readiness
    Journal Article

    Pedicord, V. A.; Cross, J. R.; Montalvo Ortiz, W.; Miller, M. L.; Allison, J. P.
    Journal of Immunology (2015)

    Fulltext@MSK | Save
  • Dissecting the therapeutic effects of anti-CTLA-4 and ADT in a murine hormone-sensitive prostate cancer
    Meeting Abstract

    Subudhi, S. K.; Montalvo-Ortiz, W.; Scher, H. I.; Allison, J. P.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of eomesodermin
    Journal Article

    Curran, M. A.; Geiger, T. L.; Montalvo, W.; Kim, M.; Reiner, S. L.; Al Shamkhani, A.; Sun, J. C.; Allison, J. P.
    Journal of Experimental Medicine (2013)

    Fulltext@MSK | Save
  • Systemic 4-1BB activation induces a novel T-cell phenotype driven by high expression of Eomesodermin
    Meeting Abstract

    Curran, M.; Geiger, T.; Montalvo, W.; Kim, M.; Reiner, S.; Al Shamkhani, A.; Sun, J.; Allison, J.
    Journal of Immunology (2012)

    Fulltext@MSK | Save
  • Improved survival with gemcitabine and CTLA-4 blockade in a murine model of prostate cancer
    Meeting Abstract

    Ariyan, C. E.; Quezada, S.; Corse, E.; Montalvo, W.; Allison, J.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production
    Journal Article

    Curran, M. A.; Kim, M.; Montalvo, W.; Al Shamkhani, A.; Allison, J. P.
    PLoS ONE (2011)

    Fulltext@MSK | Save
  • Single dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance
    Journal Article

    Pedicord, V. A.; Montalvo, W.; Leiner, I. M.; Allison, J. P.
    Proceedings of the National Academy of Sciences of the United States of America (2011)

    Fulltext@MSK | Save
  • PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
    Journal Article

    Curran, M. A.; Montalvo, W.; Yagita, H.; Allison, J. P.
    Proceedings of the National Academy of Sciences of the United States of America (2010)

    Fulltext@MSK | Save